434 related articles for article (PubMed ID: 2946360)
1. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Robertson GS; Robertson HA
Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
[TBL] [Abstract][Full Text] [Related]
2. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
3. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
4. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
5. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
6. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
7. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Paul ML; Graybiel AM; David JC; Robertson HA
J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
[TBL] [Abstract][Full Text] [Related]
8. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
Morelli M; Fenu S; Di Chiara G
Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
Karlsson G; Jaton AL; Vigouret JM
Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
Jackson DM; Ross SB; Edwards SR
J Neural Transm; 1989; 75(3):213-20. PubMed ID: 2784489
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Subramaniam S; Lucki I; McGonigle P
Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
[TBL] [Abstract][Full Text] [Related]
14. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats.
Asin KE; Montana WE
Pharmacol Biochem Behav; 1988 Jan; 29(1):89-92. PubMed ID: 3258427
[TBL] [Abstract][Full Text] [Related]
15. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.
Trugman JM; Wooten GF
J Neurosci; 1987 Sep; 7(9):2927-35. PubMed ID: 3114439
[TBL] [Abstract][Full Text] [Related]
16. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
[TBL] [Abstract][Full Text] [Related]
18. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
Winkler JD; Weiss B
J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
[TBL] [Abstract][Full Text] [Related]
19. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
Koller WC; Herbster G
Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
[TBL] [Abstract][Full Text] [Related]
20. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
Arnt J; Bøgesø KP; Hyttel J; Meier E
Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
